Purpose | Patients | Evaluations | Perceived Effectiveness |
---|---|---|---|
Dysarthria | 3 | 3 | |
Dysphonia | 1 | 0 | |
Loss of speech | 1 | 0 | |
Parkinson's disease | 1 | 2 | |
Slurred speech | 1 | 0 |
Side effect severity
Severity | Evaluations | Percentage |
---|---|---|
Severe | 0 | |
Moderate | 0 | |
Mild | 0 | |
None | 5 |